Background Given the significant impact epilepsy may have on the health‐related quality of
life (HRQOL) of individuals with epilepsy and their families, there is increasing clinical …

Introduction Psychiatric and neurologic illnesses are highly prevalent and are often
suboptimally treated. A 2015 review highlighted the value of psychiatric pharmacists in …

Objective This study was conducted to develop and achieve formal consensus on a core set
of key performance indicators (KPIs) that can be captured in measuring the impact of …

Objective To evaluate the associations between illness perception, quality of life (QOL), and
co** style among patients with epilepsy (PWE), and to establish the behavior of co** …

Background. The current study was performed to develop a consensus‐based core
inventory of key performance indicators (KPIs) to be used in capturing the impact of …

Objective To identify and describe studies about pharmacist-provided services for people
with epilepsy and their caregivers. Methods PubMed/MEDLINE and EMBASE were …

Background Antiseizure medications are commonly associated with adverse effects
including behavioral and cognitive issues, drug interactions, idiosyncratic reactions, and …

Background Quality indicators play an important role in healthcare quality and patient safety.
The aim of this study is to identify specific clinical pharmacy interventions to improve …

Background Clinical pharmacists have an important role in inter-professional healthcare
collaboration for epilepsy management. However, the pharmacy practices of managing …

Around 65 million individuals suffer from epilepsy worldwide, and when it is not properly
treated, it is linked to higher rates of physical harm and mortality. Due to the requirement for …